DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Carey I, Gersch J, Bruce M. , et al.
The markers of HBV transcriptional activity-HBcrAg and pregenomic HBV DNA during antiviral therapy with nucleos (t)ide analogue help to predict optimal timing of therapy withdrawal.
J Hepatol 2019;
70: e33-e34
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.